10.1038/s41586-019-1705-2 68
Int Immunopharmacol 77:105969 Guo C, Huang T, Chen A, Chen X, Wang L, Shen F et al (2016) Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages
BPC-157 / TB-500 is a research peptide blend combining two well-studied synthetic peptides: Body Protection Compound-157 (BPC-157) and Thymosin Beta-4 fragment TB-500. BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, while TB-500 is a synthetic peptide modeled after the naturally occurring thymosin beta-4. Together, this blend is formulated for laboratory research focused on tissue repair, angiogenesis, and cellular regeneration pathways
No evidence suggests harm, but definitive evidence of long-term safety does not exist either
It is used in common parlance
Because it contains a large amount of small molecule protein, and this is a protein that is easily absorbed by the body, replenishes collagen, promotes the formation of elastin, so that the skin can quickly restore elasticity, improve relaxation, and reduce fine lines and so on